MC2 Biotek will present its MC2-01 PAD™ Cream psoriasis project (phase II) and PAD™ Technology at Sachs 14th Annual Biotech in Europe Investor Forum in Basel on 30th October 2014 at 5pm in meeting room Lima. Jesper J. Lange, President will make the presentation. Jesper J. Lange comments: “MC2 Biotek has made significant progress across its topical pipeline in dermatology and ophthalmology. Our proprietary PAD™ Cream and Eye Drops are excellent new generation topical vehicles that enable release of the full potential of API’s, while being preferred by patients and clinicians as very comfortable and elegant.”
BACK
